{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:28:32Z","timestamp":1790944112242,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1111\/ajt.17162","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T04:34:19Z","timestamp":1658982859000},"page":"2571-2585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression"],"prefix":"10.1016","volume":"22","author":[{"given":"Pradyut K.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Drow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Nylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo Henrique","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn B.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale E.","family":"Bjorling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9374-1996","authenticated-orcid":false,"given":"Jacques","family":"Galipeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.17162_bib1","series-title":"Acute transplantation rejection.","author":"Justiz Vaillant","year":"2021"},{"key":"10.1111\/ajt.17162_bib2","doi-asserted-by":"crossref","first-page":"h3163","DOI":"10.1136\/bmj.h3163","article-title":"Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis","volume":"350","author":"Molnar","year":"2015","journal-title":"BMJ."},{"issue":"12","key":"10.1111\/ajt.17162_bib3","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1182\/blood-2008-08-171934","article-title":"HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism","volume":"113","author":"Kawase","year":"2009","journal-title":"Blood."},{"issue":"1","key":"10.1111\/ajt.17162_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e31823cab44","article-title":"Mechanisms of rejection: current perspectives","volume":"93","author":"Wood","year":"2012","journal-title":"Transplantation."},{"issue":"1461","key":"10.1111\/ajt.17162_bib5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1098\/rstb.2005.1708","article-title":"Clinical transplantation: current problems, possible solutions","volume":"360","author":"Calne","year":"2005","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"issue":"7","key":"10.1111\/ajt.17162_bib6","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2337\/dc12-0063","article-title":"Improvement in outcomes of clinical islet transplantation: 1999-2010","volume":"35","author":"Barton","year":"2012","journal-title":"Diabetes Care."},{"issue":"7","key":"10.1111\/ajt.17162_bib7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJMra032425","article-title":"Islet transplantation as a treatment for diabetes \u2013 a work in progress","volume":"350","author":"Robertson","year":"2004","journal-title":"N Engl J Med."},{"issue":"7","key":"10.1111\/ajt.17162_bib8","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1172\/JCI200423235","article-title":"Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus","volume":"114","author":"Rother","year":"2004","journal-title":"J Clin Invest."},{"issue":"13","key":"10.1111\/ajt.17162_bib9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa061267","article-title":"International trial of the Edmonton protocol for islet transplantation","volume":"355","author":"Shapiro","year":"2006","journal-title":"N Engl J Med."},{"issue":"12","key":"10.1111\/ajt.17162_bib10","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJMra1911109","article-title":"Tolerance in the age of immunotherapy","volume":"383","author":"Bluestone","year":"2020","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1111\/ajt.17162_bib11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","article-title":"PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations","volume":"15","author":"Jiang","year":"2019","journal-title":"Hum Vaccin Immunother."},{"key":"10.1111\/ajt.17162_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol."},{"key":"10.1111\/ajt.17162_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ebiom.2018.09.040","article-title":"PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-alpha and-gamma via IRF1 induction","volume":"36","author":"Colli","year":"2018","journal-title":"EBioMedicine."},{"issue":"1","key":"10.1111\/ajt.17162_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-2478(02)00142-6","article-title":"Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues","volume":"84","author":"Ishida","year":"2002","journal-title":"Immunol Lett."},{"issue":"3","key":"10.1111\/ajt.17162_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-19-0291","article-title":"Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review","volume":"181","author":"de Filette","year":"2019","journal-title":"Eur J Endocrinol."},{"key":"10.1111\/ajt.17162_bib16","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.2147\/OTT.S221340","article-title":"The role of PD-1\/PD-L1 Axis in Treg development and function: implications for cancer immunotherapy","volume":"12","author":"Cai","year":"2019","journal-title":"Onco Targets Ther."},{"issue":"33","key":"10.1111\/ajt.17162_bib17","doi-asserted-by":"crossref","first-page":"11823","DOI":"10.1073\/pnas.0505497102","article-title":"Establishment of NOD-Pdcd1\u2212\/\u2212 mice as an efficient animal model of type I diabetes","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"issue":"5380","key":"10.1111\/ajt.17162_bib18","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science."},{"issue":"5","key":"10.1111\/ajt.17162_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity."},{"issue":"6","key":"10.1111\/ajt.17162_bib20","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2005-01-0122","article-title":"Dendritic cells have the option to express IDO-mediated suppression or not","volume":"105","author":"Munn","year":"2005","journal-title":"Blood."},{"issue":"4","key":"10.1111\/ajt.17162_bib21","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.18632\/oncotarget.1637","article-title":"Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR","volume":"5","author":"Litzenburger","year":"2014","journal-title":"Oncotarget."},{"issue":"2","key":"10.1111\/ajt.17162_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/08830180903349669","article-title":"Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege","volume":"29","author":"Huang","year":"2010","journal-title":"Int Rev Immunol."},{"key":"10.1111\/ajt.17162_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fimmu.2012.00047","article-title":"The role of coinhibitory signaling pathways in transplantation and tolerance","volume":"3","author":"McGrath","year":"2012","journal-title":"Front Immunol."},{"key":"10.1111\/ajt.17162_bib24","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.4049\/jimmunol.2000055","article-title":"Localized immunomodulation with PD-L1 results in sustained survival and function of allogeneic islets without chronic immunosuppression","volume":"204","author":"Batra","year":"2020","journal-title":"J Immunol."},{"issue":"13","key":"10.1111\/ajt.17162_bib25","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1096\/fj.06-6228fje","article-title":"Sleeping beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis","volume":"20","author":"Liu","year":"2006","journal-title":"FASEB J."},{"issue":"9","key":"10.1111\/ajt.17162_bib26","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.2337\/db09-1560","article-title":"Local expression of indoleamine 2,3 dioxygenase in syngeneic fibroblasts significantly prolongs survival of an engineered three-dimensional islet allograft","volume":"59","author":"Jalili","year":"2010","journal-title":"Diabetes."},{"issue":"7830","key":"10.1111\/ajt.17162_bib27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-020-2631-z","article-title":"Immune-evasive human islet-like organoids ameliorate diabetes","volume":"586","author":"Yoshihara","year":"2020","journal-title":"Nature."},{"issue":"2","key":"10.1111\/ajt.17162_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/db13-1737","article-title":"PD-L1-driven tolerance protects neurogenin3-induced islet neogenesis to reverse established type 1 diabetes in NOD mice","volume":"64","author":"Li","year":"2015","journal-title":"Diabetes."},{"issue":"6","key":"10.1111\/ajt.17162_bib29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction and analysis","volume":"10","author":"Kelley","year":"2015","journal-title":"Nat Protoc."},{"key":"10.1111\/ajt.17162_bib30","doi-asserted-by":"crossref","first-page":"5.8.1","DOI":"10.1002\/0471250953.bi0508s52","article-title":"Protein structure and function prediction using I-TASSER","volume":"52","author":"Yang","year":"2015","journal-title":"Curr Protoc Bioinformatics."},{"issue":"1","key":"10.1111\/ajt.17162_bib31","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1038\/s41598-018-26471-9","article-title":"Interferon-gamma drives programmed death-ligand 1 expression on islet beta cells to limit T cell function during autoimmune diabetes","volume":"8","author":"Osum","year":"2018","journal-title":"Sci Rep."},{"key":"10.1111\/ajt.17162_bib32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fimmu.2016.00582","article-title":"Allorecognition by T lymphocytes and allograft rejection","volume":"7","author":"Marino","year":"2016","journal-title":"Front Immunol."},{"issue":"10","key":"10.1111\/ajt.17162_bib33","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1172\/JCI200423238","article-title":"Tregs and transplantation tolerance","volume":"114","author":"Walsh","year":"2004","journal-title":"J Clin Invest."},{"issue":"200","key":"10.1111\/ajt.17162_bib34","doi-asserted-by":"crossref","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci Transl Med."},{"issue":"5","key":"10.1111\/ajt.17162_bib35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MOT.0000000000000347","article-title":"The use of CRISPR\/Cas associated technologies for cell transplant applications","volume":"21","author":"Cowan","year":"2016","journal-title":"Curr Opin Organ Transplant."},{"issue":"3","key":"10.1111\/ajt.17162_bib36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nm1369","article-title":"Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates","volume":"12","author":"Hering","year":"2006","journal-title":"Nat Med."},{"issue":"11","key":"10.1111\/ajt.17162_bib37","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1111\/ajt.13345","article-title":"Long-term control of diabetes in immunosuppressed nonhuman primates (NHP) by the transplantation of adult porcine islets","volume":"15","author":"Shin","year":"2015","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.17162_bib38","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1399-3089.2009.00548.x","article-title":"Diabetic rats and mice are resistant to porcine and human insulin: flawed experimental models for testing islet xenografts","volume":"16","author":"Pepper","year":"2009","journal-title":"Xenotransplantation."},{"issue":"1","key":"10.1111\/ajt.17162_bib39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00006676-200207000-00020","article-title":"Xenotransplantation of pig islets in diabetic dogs with use of a microcapsule composed of agarose and polystyrene sulfonic acid mixed gel","volume":"25","author":"Kin","year":"2002","journal-title":"Pancreas."},{"issue":"5","key":"10.1111\/ajt.17162_bib40","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s00125-020-05367-2","article-title":"The promise of stem cell-derived islet replacement therapy","volume":"64","author":"Melton","year":"2021","journal-title":"Diabetologia."},{"issue":"2","key":"10.1111\/ajt.17162_bib41","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jcp.27172","article-title":"PD-1\/PD-L1 immune checkpoint: potential target for cancer therapy","volume":"234","author":"Dermani","year":"2019","journal-title":"J Cell Physiol."},{"key":"10.1111\/ajt.17162_bib42","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3389\/fimmu.2020.01185","article-title":"Immunosuppressive IDO in cancer: mechanisms of action, animal models, and targeting strategies","volume":"11","author":"Zhai","year":"2020","journal-title":"Front Immunol."},{"issue":"35","key":"10.1111\/ajt.17162_bib43","doi-asserted-by":"crossref","first-page":"eaba5573","DOI":"10.1126\/sciadv.aba5573","article-title":"Immunotherapy via PD-L1-presenting biomaterials leads to long-term islet graft survival","volume":"6","author":"Coronel","year":"2020","journal-title":"Sci Adv."},{"issue":"23","key":"10.1111\/ajt.17162_bib44","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1080\/15384101.2016.1241914","article-title":"Histone chaperone ASF1B promotes human beta-cell proliferation via recruitment of histone H3.3","volume":"15","author":"Paul","year":"2016","journal-title":"Cell Cycle."},{"issue":"5","key":"10.1111\/ajt.17162_bib45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/ph14050475","article-title":"Valproic acid suppresses autoimmune recurrence and allograft rejection in islet transplantation through induction of the differentiation of regulatory T cells and can be used in cell therapy for type 1 diabetes","volume":"14","author":"Lin","year":"2021","journal-title":"Pharmaceuticals (Basel)."},{"issue":"5","key":"10.1111\/ajt.17162_bib46","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1600-6143.2011.03943.x","article-title":"Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice","volume":"12","author":"Shi","year":"2012","journal-title":"Am J Transplant."},{"issue":"12","key":"10.1111\/ajt.17162_bib47","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.2337\/diabetes.54.12.3395","article-title":"On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes","volume":"54","author":"Bruder","year":"2005","journal-title":"Diabetes."},{"issue":"17","key":"10.1111\/ajt.17162_bib48","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1073\/pnas.0802644105","article-title":"Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice","volume":"105","author":"Mukhopadhaya","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"10.1111\/ajt.17162_bib49","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/1744666X.2019.1620602","article-title":"Regulatory T cells: the future of autoimmune disease treatment","volume":"15","author":"Ryba-Stanislawowska","year":"2019","journal-title":"Expert Rev Clin Immunol."},{"issue":"11","key":"10.1111\/ajt.17162_bib50","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrd.2018.148","article-title":"Regulatory T cells in the treatment of disease","volume":"17","author":"Sharabi","year":"2018","journal-title":"Nat Rev Drug Discov."},{"issue":"315","key":"10.1111\/ajt.17162_bib51","doi-asserted-by":"crossref","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med."},{"issue":"4","key":"10.1111\/ajt.17162_bib52","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J Clin Invest."},{"issue":"8","key":"10.1111\/ajt.17162_bib53","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41563-018-0099-0","article-title":"Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance","volume":"17","author":"Headen","year":"2018","journal-title":"Nat Mater."},{"issue":"13","key":"10.1111\/ajt.17162_bib54","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J exp Med."},{"issue":"3","key":"10.1111\/ajt.17162_bib55","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1600-0897.2007.00510.x","article-title":"Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells","volume":"58","author":"Terness","year":"2007","journal-title":"Am J Reprod Immunol."},{"issue":"12","key":"10.1111\/ajt.17162_bib56","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.2337\/db18-0709","article-title":"Increase functional beta-cell mass in subcutaneous alginate capsules with porcine prenatal islet cells but loss with human adult islet cells","volume":"67","author":"De Mesmaeker","year":"2018","journal-title":"Diabetes."}],"updated-by":[{"DOI":"10.1016\/j.ajt.2023.02.019","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000}}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.17162","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.17162","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522299730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522299730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.17162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T17:40:48Z","timestamp":1674409248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522299730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1600613522299730"],"URL":"https:\/\/doi.org\/10.1111\/ajt.17162","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ajt.2023.02.019","asserted-by":"object"}]},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.17162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}